Drugs / Insulin VIAject™
last change Aug 2008 re-read 2 minutes ago

Insulin VIAject™

Developed for
type 2 diabetes mellitus
Investigated by
Biodel

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00849576 Apr → Aug 2008 type 2 diabetes mellitus Biodel Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Insulin VIAject ClinicalTrials.gov intervention name — accepted as the source's own label NCT00849576